Literature DB >> 28032206

Ovarian Adrenal Rest Tumors Undetected by Imaging Studies and Identified at Surgery in Three Females with Congenital Adrenal Hyperplasia Unresponsive to Increased Hormone Therapy Dosage.

Hua-Dong Chen1, Li-E Huang1, Zhi-Hai Zhong1, Zhe Su2, Hong Jiang1, Jing Zeng3, Jun-Cheng Liu4.   

Abstract

Patients with congenital adrenal hyperplasia have a predisposition for developing adrenal rest tumors. In contrast to testicular adrenal rest tumors, ovarian adrenal rest tumors are less common, and only a few cases have been reported in the literature. This report presents three Chinese female congenital adrenal hyperplasia patients (9 to 15 years of age) with small ectopic adrenal cortical nodules that were not detected by imaging but were diagnosed at surgery. All three patients developed virilization with elevation of 17- hydroxyprogesterone, androstenedione, and androgen levels despite receiving maximum adrenal hormone replacement therapy. Ultrasound and magnetic resonance imaging of the abdomen and pelvis suggested bilateral expansion of the adrenal glands, but no lesions of the ovaries were observed. Laparoscopy and/or laparotomy revealed small nodular lesions surrounding the pelvic gonad in all three cases. Histopathological examination of the resected tissue in all cases revealed hyperplasic nodules of cells surrounded by fibrous tissue. The cells were arranged as nests with abundant cytoplasm, which were partially lightly stained with a small centered nucleus. Immunohistochemistry staining revealed the cells to be synaptophysin positive, melan-A positive, and chromogranin A negative, indicating the cells were adrenocortical tissue and not adrenal medullary cells. Thus, the findings of the histopathological examination were consistent with ovarian adrenal rest tumors. Female congenital adrenal hyperplasia patients with virilization who showed an inadequate response to hormone therapy and had negative imaging results may benefit from laparoscopic examination or laparotomy in order to confirm the diagnosis of ovarian adrenal rest tumors while receiving unilateral subtotal adrenalectomy or subtotal bilateral adrenalectomy.

Entities:  

Keywords:  Adrenal rest tumor; Congenital adrenal hyperplasia; Laparoscopy; Ovarian adrenal rest tumor

Mesh:

Year:  2017        PMID: 28032206     DOI: 10.1007/s12022-016-9461-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  15 in total

1.  Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings.

Authors:  N A Avila; A Premkumar; D P Merke
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

2.  Long term outcome in adult males with classic congenital adrenal hyperplasia.

Authors:  M S Cabrera; M G Vogiatzi; M I New
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

3.  Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy.

Authors:  Dov Tiosano; Euvgeni Vlodavsky; Shlomo Filmar; Zeev Weiner; Dorit Goldsher; Rachel Bar-Shalom
Journal:  Horm Res Paediatr       Date:  2010-05-01       Impact factor: 2.852

4.  Bilateral ovary adrenal rest tumor in a congenital adrenal hyperplasia following adrenalectomy.

Authors:  Magda G Zaarour; David M Atallah; Viviane E Trak-Smayra; Georges H Halaby
Journal:  Endocr Pract       Date:  2014-04       Impact factor: 3.443

5.  Ovarian adrenal rest tissue in congenital adrenal hyperplasia--a patient report.

Authors:  H L Claahsen-van der Grinten; C A Hulsbergen-van de Kaa; B J Otten
Journal:  J Pediatr Endocrinol Metab       Date:  2006-02       Impact factor: 1.634

6.  Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Hedi L Claahsen-van der Grinten; Fred C G J Sweep; Johan G Blickman; Ad R M M Hermus; Barto J Otten
Journal:  Eur J Endocrinol       Date:  2007-09       Impact factor: 6.664

7.  Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia.

Authors:  Melissa K Crocker; Stephanie Barak; Corina M Millo; Stephanie A Beall; Mahtab Niyyati; Richard Chang; Nilo A Avila; Carol Van Ryzin; James Segars; Martha Quezado; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

Review 8.  Testicular adrenal rest tumours in congenital adrenal hyperplasia.

Authors:  H L Claahsen-van der Grinten; B J Otten; M M L Stikkelbroeck; F C G J Sweep; A R M M Hermus
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690

9.  An adrenal rest tumour in the perirenal region in a patient with congenital adrenal hyperplasia due to congenital 3beta-hydroxysteroid dehydrogenase deficiency.

Authors:  Hedi L Claahsen-van der Grinten; Kristof Duthoi; Barto J Otten; Frank C H d'Ancona; Christina A Hulsbergen-vd Kaa; Ad R M M Hermus
Journal:  Eur J Endocrinol       Date:  2008-07-22       Impact factor: 6.664

Review 10.  Ovarian steroid cell tumor, not otherwise specified, associated with congenital adrenal hyperplasia: rare tumors of an endocrine disease.

Authors:  Tina T Thomas; Kimberly R Ruscher; Srinivas Mandavilli; Fabiola Balarezo; Christine M Finck
Journal:  J Pediatr Surg       Date:  2013-06       Impact factor: 2.545

View more
  9 in total

Review 1.  [Ectopia of the adrenal].

Authors:  W Saeger
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

2.  Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal Hyperplasia, and Triple Translocation: Is a Consequence or Coincidence?

Authors:  Sami Akbulut; Senay Durmaz Ceylan; Timur Tuncali; Nilgun Sogutcu
Journal:  J Gastrointest Cancer       Date:  2021-06

Review 3.  Congenital Adrenal Hyperplasia.

Authors:  Selma Feldman Witchel
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-04-24       Impact factor: 1.814

4.  Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria.

Authors:  Asmahane Ladjouze; Malcolm Donaldson; Ingrid Plotton; Nacima Djenane; Kahina Mohammedi; Véronique Tardy-Guidollet; Delphine Mallet; Kamélia Boulesnane; Zair Bouzerar; Yves Morel; Florence Roucher-Boulez
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

5.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

6.  Prevalence and ultrasound patterns of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia.

Authors:  Beniamino Corcioni; Matteo Renzulli; Giovanni Marasco; Federico Baronio; Alessandra Gambineri; Domenico Ricciardi; Rita Ortolano; Davide Farina; Caterina Gaudiano; Alessandra Cassio; Uberto Pagotto; Rita Golfieri
Journal:  Transl Androl Urol       Date:  2021-02

Review 7.  Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.

Authors:  Ozgur Mete; Lori A Erickson; C Christofer Juhlin; Ronald R de Krijger; Hironobu Sasano; Marco Volante; Mauro G Papotti
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 4.056

8.  Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia.

Authors:  Wen-Hsuan Tsai; Chian-Huey Wong; Shuen-Han Dai; Chung-Hsin Tsai; Yi-Hong Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

9.  Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.

Authors:  Kyriakie Sarafoglou; Chris N Barnes; Michael Huang; Erik A Imel; Ivy-Joan Madu; Deborah P Merke; David Moriarty; Samer Nakhle; Ron S Newfield; Maria G Vogiatzi; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.